Long-Term Vitiligo Data Appear To Lay Opzelura Safety Concerns To Rest

 
• By Alaric DeArment
  
Incyte announced updated data for topical JAK inhibitor Opzelura in vitiligo • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Dermatological

More from Therapeutic Category